Related references
Note: Only part of the references are listed.Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophils
Alvaro Teijeira et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Transforming growth factor-beta in tissue fibrosis
Nikolaos G. Frangogiannis
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Neutrophil chemoattractant receptors in health and disease: double-edged swords
Mieke Metzemaekers et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Effects of Nintedanib in an Animal Model of Liver Fibrosis
Lutz Wollin et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Protein tyrosine phosphatase-α amplifies transforming growth factor-β-dependent profibrotic signaling in lung fibroblasts
Yael Aschner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
Src family kinases and pulmonary fibrosis: A review
Hang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
PAD4 Deficiency Improves Bleomycin-induced Neutrophil Extracellular Traps and Fibrosis in Mouse Lung
Masaki Suzuki et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis
Matea Cedilak et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2019)
Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1
Jin Jin et al.
RESPIRATORY RESEARCH (2019)
Fibrosis: Lessons from OMICS analyses of the human lung
Guoying Yu et al.
MATRIX BIOLOGY (2018)
Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis
Mareike Lehmann et al.
RESPIRATORY RESEARCH (2018)
RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase
Mitsuru Imamura et al.
JCI INSIGHT (2018)
Pulmonary fibrosis requires cell-autonomous mesenchymal fibroblast growth factor (FGF) signaling
Robert D. Guzy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Idiopathic pulmonary fibrosis
Luca Richeldi et al.
LANCET (2017)
Netting Insights into Fibrosis
Stefanie Dimmeler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The diagnosis of idiopathic pulmonary fibrosis: current and future approaches
Fernando J. Martinez et al.
LANCET RESPIRATORY MEDICINE (2017)
Interaction of Src and Alpha-V Integrin Regulates Fibroblast Migration and Modulates Lung Fibrosis in A Preclinical Model of Lung Fibrosis
Yin-Ying Lu et al.
SCIENTIFIC REPORTS (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
A review of connectivity map and computational approaches in pharmacogenomics (bbw112, 2017)
Aliyu Musa et al.
BRIEFINGS IN BIOINFORMATICS (2017)
An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices
Hani N. Alsafadi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis
Argyrios Tzouvelekis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Jingang Huang et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease
Yael Aschner et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Effect of saracatinib on pulmonary metastases from hepatocellular carcinoma
Ju Xiong et al.
ONCOLOGY REPORTS (2016)
Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd
Zichen Wang et al.
NATURE COMMUNICATIONS (2016)
Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
Gareth Hughes et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures
Franziska E. Uhl et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway
Andrea M. Brum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis
Tamera Corte et al.
RESPIRATORY RESEARCH (2015)
Protein Tyrosine Phosphatase α Mediates Profibrotic Signaling in Lung Fibroblasts through TGF-β Responsiveness
Yael Aschner et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Matrix Biology of Idiopathic Pulmonary Fibrosis A Workshop Report of the National Heart, Lung, and Blood Institute
Victor J. Thannickal et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11
Ganesh Raghu et al.
LANCET RESPIRATORY MEDICINE (2014)
Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
Meng Hu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
Katrin E. Hostettler et al.
RESPIRATORY RESEARCH (2014)
Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for Active Disease
Ruoqi Peng et al.
PLOS ONE (2013)
Axin Pathway Activity Regulates in Vivo pY654-β-catenin Accumulation and Pulmonary Fibrosis
Arnau Ulsamer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle
Eric B. Meltzer et al.
BMC MEDICAL GENOMICS (2011)
Integrating mechanisms of pulmonary fibrosis
Thomas A. Wynn
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Max A. Seibold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Joel T. Dudley et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Marina Sirota et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Antifibrotic activities of pirfenidone in animal models
C. J. Schaefer et al.
EUROPEAN RESPIRATORY REVIEW (2011)
Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors
Jose Baselga et al.
CLINICAL CANCER RESEARCH (2010)
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
Tim P. Green et al.
MOLECULAR ONCOLOGY (2009)
Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling
Ramars Amanchy et al.
MOLECULAR ONCOLOGY (2009)
Are animal models predictive for humans?
Niall Shanks et al.
Philosophy Ethics and Humanities in Medicine (2009)
Murine models of pulmonary fibrosis
Bethany B. Moore et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Transforming growth factor β1 induces αvβ3 integrin expression in human lung fibroblasts via a β3 integrin-, c-Src-, and p38 MAPK-dependent pathway
Dmitri V. Pechkovsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530
Y-M Chang et al.
ONCOGENE (2008)
Telomerase mutations in families with idiopathic pulmonary fibrosis
Mary Y. Armanios et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Two functionally distinct pools of Src kinases for PDGF receptor signalling
L Veracini et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
A Abdollahi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly
DJ Webb et al.
NATURE CELL BIOLOGY (2004)
Structure and regulation of Src family kinases
TJ Boggon et al.
ONCOGENE (2004)
Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis
N Kaminski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
